We welcomed two special guests, Dr. Stacy Lindborg, CEO of IMUNON, and Dr. Premal Thaker, Gynecologic Oncologist at Washington University, to discuss the results of the OVATION 2 Study and the latest ...
The next-generation weight loss therapeutic, nimacimab, has entered the Phase 2 CBeyond clinical trial. The study aims to determine the safety of nimacimab, focusing on sustainable weight loss and ...
This website is organized and funded by Health and Pharma and it is not intended for a specific location or country; it represents a fully international brand. Additionally, it contains promotional ...